Literature DB >> 1596516

Arachidonic acid metabolism in isolated pancreatic islets. VI. Carbohydrate insulin secretagogues must be metabolized to induce eicosanoid release.

J Turk1, M Mueller, A Bohrer, S Ramanadham.   

Abstract

Pancreatic islets stimulated with D-glucose are known to liberate arachidonic acid from membrane phospholipids and release prostaglandin E2 (PGE2). A component of the eicosanoid release induced by D-glucose has been demonstrated to occur without calcium influx and must be triggered by other coupling mechanisms. In this study, we have attempted to identify mechanisms other than calcium influx which might couple D-glucose stimulation to hydrolysis of arachidonate from membrane phospholipids in islet cells. We have found that occupancy of the beta cell plasma membrane D-glucose transporter is insufficient and that D-glucose metabolism is required to induce islet PGE2 release because 3-O-methylglucose fails to induce and mannoheptulose prevents PGE2 release otherwise induced by 17 mM D-glucose. The carbohydrate insulin secretagogues mannose and D-glyceraldehyde have also been found to induce islet PGE2 release, but the non-secretagogue carbohydrates L-glucose and lactate do not. Carbohydrate secretagogues are known to be metabolized to yield ATP and induce depolarization of the beta cell plasma membrane. We have found that depolarization by 40 mM KCl induces PGE2 release only in the presence and not in the absence of extracellular calcium, but exogenous ATP induces islet PGE2 release with or without extracellular calcium. Carbachol is demonstrated here to interact synergistically with increasing concentrations of glucose to amplify PGE2 release and insulin secretion. Pertussis toxin treatment is shown here not to prevent PGE2 release induced by glucose or carbachol but to increase the basal rate of PGE2 release and the islet cyclic AMP content. Theophylline (10 mM) exerts similar effects. Eicosanoid release in pancreatic islets can thus be activated by multiple pathways including muscarinic receptor occupancy, calcium influx, increasing cAMP content, and a metabolic signal derived from nutrient secretagogues, such as ATP.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1596516     DOI: 10.1016/0005-2760(92)90057-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

Review 1.  Phospholipase A2 and its potential regulation of islet function.

Authors:  E Simonsson; B Ahrén
Journal:  Int J Pancreatol       Date:  2000-02

Review 2.  Islet complex lipids: involvement in the actions of group VIA calcium-independent phospholipase A(2) in beta-cells.

Authors:  Sasanka Ramanadham; Haowei Song; Shunzhong Bao; Fong-Fu Hsu; Sheng Zhang; Zhongmin Ma; Chun Jin; John Turk
Journal:  Diabetes       Date:  2004-02       Impact factor: 9.461

3.  Insulin secretory responses and phospholipid composition of pancreatic islets from mice that do not express Group VIA phospholipase A2 and effects of metabolic stress on glucose homeostasis.

Authors:  Shunzhong Bao; Haowei Song; Mary Wohltmann; Sasanka Ramanadham; Wu Jin; Alan Bohrer; John Turk
Journal:  J Biol Chem       Date:  2006-05-27       Impact factor: 5.157

4.  Modulation of the pancreatic islet beta-cell-delayed rectifier potassium channel Kv2.1 by the polyunsaturated fatty acid arachidonate.

Authors:  David A Jacobson; Christopher R Weber; Shunzhong Bao; John Turk; Louis H Philipson
Journal:  J Biol Chem       Date:  2006-12-29       Impact factor: 5.157

5.  Effects of stable suppression of Group VIA phospholipase A2 expression on phospholipid content and composition, insulin secretion, and proliferation of INS-1 insulinoma cells.

Authors:  Shunzhong Bao; Alan Bohrer; Sasanka Ramanadham; Wu Jin; Sheng Zhang; John Turk
Journal:  J Biol Chem       Date:  2005-11-14       Impact factor: 5.157

6.  Group VIA PLA2 (iPLA2β) is activated upstream of p38 mitogen-activated protein kinase (MAPK) in pancreatic islet β-cell signaling.

Authors:  Haowei Song; Mary Wohltmann; Min Tan; Shunzhong Bao; Jack H Ladenson; John Turk
Journal:  J Biol Chem       Date:  2011-12-22       Impact factor: 5.157

Review 7.  Calcium-independent phospholipases A2 and their roles in biological processes and diseases.

Authors:  Sasanka Ramanadham; Tomader Ali; Jason W Ashley; Robert N Bone; William D Hancock; Xiaoyong Lei
Journal:  J Lipid Res       Date:  2015-05-28       Impact factor: 5.922

8.  Group VIA Phospholipase A2 (iPLA2β) Modulates Bcl-x 5'-Splice Site Selection and Suppresses Anti-apoptotic Bcl-x(L) in β-Cells.

Authors:  Suzanne E Barbour; Phuong T Nguyen; Margaret Park; Bhargavi Emani; Xiaoyong Lei; Mamatha Kambalapalli; Jacqueline C Shultz; Dayanjan Wijesinghe; Charles E Chalfant; Sasanka Ramanadham
Journal:  J Biol Chem       Date:  2015-03-11       Impact factor: 5.157

9.  Inhibition of Ca2+-independent phospholipase A2 results in insufficient insulin secretion and impaired glucose tolerance.

Authors:  Keying Song; Xu Zhang; Chunying Zhao; Natasha T Ang; Zhongmin Alex Ma
Journal:  Mol Endocrinol       Date:  2004-10-07

10.  Characterization of FKGK18 as inhibitor of group VIA Ca2+-independent phospholipase A2 (iPLA2β): candidate drug for preventing beta-cell apoptosis and diabetes.

Authors:  Tomader Ali; George Kokotos; Victoria Magrioti; Robert N Bone; James A Mobley; William Hancock; Sasanka Ramanadham
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.